Clinical Trials Sponsored by Vera Therapeutics, Inc.
Total 2979 results
-
ImmuneOncia Therapeutics Inc.Not yet recruitingA Study of Phase2, IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor (TMB-H)TMB-H | Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors
-
Axsome Therapeutics, Inc.RecruitingMajor Depressive DisorderUnited States
-
Actym Therapeutics, Inc.Not yet recruiting
-
Nested Therapeutics, IncRecruitingGlioma | Melanoma | NSCLC | Oncology | Solid Tumor, Adult | MEK Mutation | RAF Gene Mutation | Ras (KRAS or NRAS) Gene Mutation | MAPK Pathway Gene MutationAustralia
-
Viracta Therapeutics, Inc.Recruiting
-
Biora Therapeutics, Inc.Recruiting
-
Pliant Therapeutics, Inc.RecruitingMetastatic Solid TumorUnited States
-
Carisma Therapeutics IncRecruiting
-
Iambic Therapeutics, IncRecruiting
-
Sarepta Therapeutics, Inc.RecruitingLimb-girdle Muscular DystrophyUnited States
-
Travere Therapeutics, Inc.Recruiting
-
Pyrotech Therapeutics, Inc.RecruitingLocally Advanced or Metastatic Solid TumorsUnited States
-
OnCusp Therapeutics, Inc.RecruitingOvarian Cancer | Solid TumorUnited States
-
Axsome Therapeutics, Inc.RecruitingMajor Depressive DisorderUnited States
-
Synnovation Therapeutics, Inc.Recruiting
-
Multitude Therapeutics Inc.Recruiting
-
Akero Therapeutics, IncRecruitingNASH/MASH | NAFLD/MASLDUnited States, Canada, Puerto Rico, Australia, India
-
Verve Therapeutics, Inc.Not yet recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Edgewise Therapeutics, Inc.RecruitingDuchenne Muscular DystrophyUnited States
-
Pliant Therapeutics, Inc.RecruitingIdiopathic Pulmonary FibrosisUnited States, Australia, Taiwan, Korea, Republic of, Portugal, Germany, Israel, Denmark, New Zealand, Netherlands, Canada, Chile, Czechia, France, Greece, Italy, Poland
-
Carmot Therapeutics, Inc.RecruitingOverweight | Type 1 Diabetes Mellitus | ObeseUnited States
-
Scorpion Therapeutics, Inc.RecruitingNon-Small Cell Lung Cancer | NSCLC | EGFR/HER2 Exon 20 Insertion MutationUnited States, Taiwan
-
Neumora Therapeutics, Inc.RecruitingMajor Depressive DisorderUnited States
-
Cyrano Therapeutics, Inc.Recruiting
-
Relmada Therapeutics, Inc.RecruitingDepression | Major Depressive DisorderUnited States
-
Keros Therapeutics, Inc.RecruitingPulmonary Arterial HypertensionUnited States, Australia
-
TScan Therapeutics, Inc.RecruitingMelanoma | Cervical Cancer | Head and Neck Cancer | HPV-Related Malignancy | Ovarian Cancer | HPV-Related Carcinoma | HPV-Related Cervical Carcinoma | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Non-small Cell Carcinoma | HPV - Anogenital Human Papilloma Virus Infection | HPV-Related Adenocarcinoma | HPV-Related Adenosquamous Carcinoma and other conditionsUnited States
-
NextPoint Therapeutics, Inc.RecruitingMetastatic Malignant NeoplasmUnited States
-
Lung Therapeutics, IncRecruitingIdiopathic Pulmonary FibrosisUnited States, United Kingdom, Germany
-
BioAegis Therapeutics Inc.Not yet recruitingInfections | Acute Respiratory Distress Syndrome
-
Beam Therapeutics Inc.RecruitingLymphoblastic Lymphoma | Lymphoblastic Leukemia | T-Cell Lymphoblastic Leukemia/LymphomaUnited States
-
Orbus Therapeutics, Inc.RecruitingGlioblastoma | Glioblastoma Multiforme | GBM | Glioblastoma, IDH-wildtype | Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeUnited States
-
Atsena Therapeutics Inc.RecruitingX-linked RetinoschisisUnited States
-
G1 Therapeutics, Inc.RecruitingExtensive-stage Small-cell Lung CancerSpain, Greece, Turkey, Poland, Georgia, Austria, Belgium, Bulgaria, Germany, Hungary
-
Travere Therapeutics, Inc.RecruitingImmunoglobulin A NephropathyUnited States, Hong Kong
-
LAPIX Therapeutics Inc.RecruitingMultiple Sclerosis | Autoimmune DiseasesUnited States, Jordan
-
ImmuneSensor Therapeutics Inc.RecruitingOligoprogressiveUnited States
-
Aviceda Therapeutics, Inc.RecruitingMacular Degeneration | Geographic Atrophy of the MaculaUnited States
-
AnHeart Therapeutics Inc.RecruitingIDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid TumorCholangiocarcinoma With IDH1 Mutation | Solid Tumors With IDH1 MutationChina
-
Marker Therapeutics, Inc.RecruitingNon Hodgkin Lymphoma | Non-Hodgkin Lymphoma, Adult | Non-Hodgkin Lymphoma, Refractory | Non-Hodgkin Lymphoma, RelapsedUnited States
-
Kymera Therapeutics, Inc.RecruitingAdvanced Solid Tumors | Acute Lymphocytic Leukemia | Lymphomas | Myeloid MalignanciesUnited States
-
Zucara Therapeutics Inc.RecruitingType 1 Diabetes Mellitus With HypoglycemiaUnited States, Canada
-
Multitude Therapeutics Inc.Recruiting
-
Abeona Therapeutics, IncRecruitingEpidermolysis Bullosa | Recessive Dystrophic Epidermolysis Bullosa | RDEBUnited States
-
Lisata Therapeutics, Inc.RecruitingCholangiocarcinoma | Bile Duct Cancer | Intrahepatic Cholangiocarcinoma | Gallbladder Carcinoma | Gallbladder Cancer | Gall Bladder Cancer | Extrahepatic Cholangiocarcinoma | Gall Bladder CarcinomaUnited States, Spain
-
Sustained Therapeutics Inc.Recruiting
-
C4 Therapeutics, Inc.RecruitingMelanoma | NSCLC | Solid Tumors | CRC | ATCUnited States, Spain, France
-
Palvella Therapeutics, Inc.RecruitingPachyonychia CongenitaUnited States
-
Inhibikase Therapeutics, Inc.Recruiting
-
Cyclo Therapeutics, Inc.RecruitingAlzheimer's DiseaseUnited States